Compare AVO & PRME Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | AVO | PRME |
|---|---|---|
| Founded | 1983 | 2019 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Farming/Seeds/Milling | Medicinal Chemicals and Botanical Products |
| Sector | Consumer Staples | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 818.6M | 666.1M |
| IPO Year | 2020 | 2022 |
| Metric | AVO | PRME |
|---|---|---|
| Price | $11.57 | $3.46 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 1 | 5 |
| Target Price | ★ $17.00 | $6.42 |
| AVG Volume (30 Days) | 584.5K | ★ 3.8M |
| Earning Date | 12-18-2025 | 11-07-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 2.33 | N/A |
| EPS | ★ 0.53 | N/A |
| Revenue | ★ $1,391,200,000.00 | $5,977,000.00 |
| Revenue This Year | N/A | $111.80 |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | $21.85 | ★ N/A |
| Revenue Growth | 12.68 | ★ 647.13 |
| 52 Week Low | $9.56 | $1.11 |
| 52 Week High | $14.49 | $6.94 |
| Indicator | AVO | PRME |
|---|---|---|
| Relative Strength Index (RSI) | 38.73 | 41.10 |
| Support Level | $11.49 | $3.29 |
| Resistance Level | $12.02 | $4.12 |
| Average True Range (ATR) | 0.44 | 0.24 |
| MACD | -0.13 | -0.02 |
| Stochastic Oscillator | 4.14 | 17.12 |
Mission Produce Inc produces, packs, and distributes mainly Hass avocados to retail, wholesale, and food service customers, offering pre-ripe and ripened fruit tailored to customer specifications through its network of ripening facilities. The Company operates through three segments: Marketing & Distribution, which sources and distributes fruit globally and generates the majority of revenue; International Farming, which owns and operates avocado orchards and supplies fruit mainly to Marketing & Distribution, with operations principally in Peru and Guatemala; and Blueberries, which farms blueberries sold under an exclusive marketing agreement. The Company's operations span Peru, the United States, Guatemala, Mexico, Europe, and Canada.
Prime Medicine Inc is a biotechnology company committed to delivering genetic therapies to address diseases by deploying gene editing technology, Prime Editing. The Prime Editing technology is a next-generation technology that can search and replace to restore normal genetic function in the genome and can treat a wide spectrum of diseases with high unmet medical needs and efficient and broad gene editing technology.